Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

FENOFIBRATE 48 MG TABLET

FENOFIBRATE
$0.0828per EA

Strength

48 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097045905

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

FENOFIBRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA208709

On Market Since

12/15/2016

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist

Price History

1W

0.0%

1M

-0.1%

3M

-2.5%

6M

-8.9%

1Y

-18.9%

3Y

-20.8%

5Y

-35.2%

All

-80.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

FENOFIBRATE 54 MG TABLET
Generic
69367025709•Westminster Pharmaceuticals LLC
$0.0630
per EA
PIOGLITAZONE HCL 15 MG TABLET
Generic
00093727105•Teva Pharmaceuticals USA Inc.
$0.0698
per EA
PIOGLITAZONE HCL 15 MG TABLET
Generic
00093727156•Teva Pharmaceuticals USA Inc.
$0.0698
per EA
PIOGLITAZONE HCL 15 MG TABLET
Generic
00093727198•Teva Pharmaceuticals USA Inc.
$0.0698
per EA
PIOGLITAZONE HCL 15 MG TABLET
Generic
00904709061•Major Pharmaceuticals
$0.0698
per EA
PIOGLITAZONE HCL 15 MG TABLET
Generic
16714064501•NorthStar Rx LLC
$0.0698
per EA
PIOGLITAZONE HCL 15 MG TABLET
Generic
16714064502•NorthStar Rx LLC
$0.0698
per EA
PIOGLITAZONE HCL 15 MG TABLET
Generic
16714064503•NorthStar Rx LLC
$0.0698
per EA
PIOGLITAZONE HCL 15 MG TABLET
Generic
33342005407•Macleods Pharmaceuticals Limited
$0.0698
per EA
PIOGLITAZONE HCL 15 MG TABLET
Generic
33342005410•Macleods Pharmaceuticals Limited
$0.0698
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy